Sugammadex in clinical practice

Anaesthesia

Volumn 64, Issue SUPPL. 1, 2009, Pages 45-54

  Mirakhur, R K ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CISATRACURIUM; CONTRACEPTIVE AGENT; FLUCLOXACILLIN; FUSIDIC ACID; GESTAGEN; NEOSTIGMINE; NEUROMUSCULAR BLOCKING AGENT; PANCURONIUM; PLACEBO; ROCURONIUM; SEVOFLURANE; SUGAMMADEX; SUXAMETHONIUM; TOREMIFENE; VECURONIUM;

ABSENCE OF SIDE EFFECTS; CLINICAL PRACTICE; COUGHING; DOSE RESPONSE; DRUG ANTAGONISM; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG ELIMINATION; DRUG EXCRETION; DRUG HALF LIFE; DRUG POTENCY; DRUG SAFETY; DRUG TOLERABILITY; FLUSHING; HEART PALPITATION; HUMAN; NEUROMUSCULAR BLOCKING; NONHUMAN; REVIEW; SENSATION; SIDE EFFECT; TACHYCARDIA;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANESTHESIA RECOVERY PERIOD; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; GAMMA-CYCLODEXTRINS; HUMANS; MIDDLE AGED; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR JUNCTION; NEUROMUSCULAR NONDEPOLARIZING AGENTS; YOUNG ADULT;

EID: 61849148161     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/j.1365-2044.2008.05870.x     Document Type: Review

References (56)

1. Carroll MT, Mirakhur RK, Lowry DW, McCourt KC, Kerr C. Neuromuscular blocking effects and train-of-four fade with cisatracurium: comparison with other non-depolarising relaxants. Anaesthesia 1998; 53: 1169-73.
2. McCourt KC, Mirakhur RK, Kerr CM. Dosage of neostigmine for reversal of rocuronium block from two levels of spontaneous recovery. Anaesthesia 1999; 54: 651-5.
3. Baillard C, Gehan G, Reboul-Marty J, Larmignat P, Samama CM, Cupa M. Residual curarization in the recovery room after vecuronium. British Journal of Anaesthesia 2000; 84: 394-5.
4. Connolly FM, Mirakhur RK, Loan PB, McCoy EP, Symington M, Kumar N. Antagonism of mivacurium block with edrophonium from various degrees of spontaneous recovery. British Journal of Anaesthesia 1995; 74: 229-30.
5. Soni N, Kam P. 4-aminopyridine, a review. Anaesthesia and Intensive Care 1982; 10: 120-6.
6. Bowman WC. Reversal agents. In: Bowman WC, ed. Pharmacology of Neuromuscular Function, 2nd edn. London, UK: Wright, 1990: 196-202.
7. Magorian TT, Lynam DP, Caldwell J, Miller RD. Can early administration of neostigmine, in single or divided doses, alter the course of neuromuscular recovery from a vecuronium-induced neuromuscular blockade? Anesthesiology 1990; 73: 410-4.
8. Hayes AH, Mirakhur RK, Breslin DS, Reid JE, McCourt KC. Postoperative residual block after intermediate-acting neuromuscular blocking drugs. Anaesthesia 2001; 56: 312-8.
9. Payne JP, Hughes R, Al Azawi S. Neuromuscular blockade by neostigmine in anaesthetized man. British Journal of Anaesthesia 1980; 52: 69-76.
10. Booij LHDJ. Cyclodextrins and the emergence of sugammadex. Anaesthesia 2009; 64: 31-37.
11. Booij LHDJ, van Egmond J, Driessen JJ, de Boer HD. In vivo animal studies with sugammadex. Anaesthesia 2009; 64: 38-44.
12. Gijsenbergh F, Ramael S, Houwing N, van Iersel T. First human exposure of Org 25969, a novel agent to reverse the action of rocuronium bromide. Anesthesiology 2005; 103: 695-703.
13. Decoopman M, Cammu G, Suy K, Heeringa M, Demeyer I. Reversal of pancuronium-induced block by the selective relaxant binfing agent sugammadex. European Journal of Anaesthesiology 2007; 24 (Suppl. 39): 110.
14. Sorgenfrei IF, Norril DK, Larsen BV, et al. The reversal of rocuronium induced neuromuscular block by the selective relaxant binding agent sugammadex. Anaesthesiology 2006; 104: 667-74.
15. Sundman E, Witt H, Olsson R, Ekberg O, Kuylenstierna R, Eriksson LI. The incidence and mechanisms of pharyngeal and upper esophageal dysfunction in partially paralyzed humans. Anesthesiology 2000; 92: 977-84.
16. Eikermann M, Blobner M, Groeben H, et al. Postoperative upper airway obstruction after recovery of the train-of-four ratio of the adductor pollicis muscle from neuromuscular blockade. Anesthesia and Analgesia 2006; 102: 937-42.
17. Shields M, Giovannelli M, Mirakhur RK, Moppett I, Adams J, Hermens Y. Org 25969 (sugammadex), a selective relaxant binding agent for antagonism of prolonged rocuronium-induced neuromuscular block. British Journal of Anaesthesia 2006; 96: 36-43.
18. Suy K, Morias K, Cammu G, Hans P, van Duijnhoven WGF. Effective reversal of moderate rocuronium- or vecuronium-induced neuromuscular block with sugammadex, a selective relaxant binding agent. Anesthesiology 2007; 106: 283-8.
19. Pühringer F, Blaszyk M, Gammu G, Sparr H, Heeringa M. Sugammadex achieves fast recovery from shallow neuromuscular blockade induced by rocuronium or vecuronium: dose-response studies. European Journal of Anaesthesiology 2007; 24 (Suppl. 39): 111.
20. Plaud B, Meretoja O, Pohl B, Mirakhur RK, Raft J. Reversal of rocuronium-induced neuromuscular blockade with sugammadex in paediatric and adult patients. European Journal of Anaesthesiology 2007; 24 (Suppl. 39): 124.
21. Blobner M, Eriksson L, Scholz J, Hillebrand H, Pompei L. Sugammadex (2 mg/kg) significantly faster reverses shallow rocuronium-induced neuromuscular blockade compared with Neostigmine (50 μg/kg). European Journal of Anaesthesiology 2007; 24 (Suppl. 39): 125-6.
22. Blobner M, Rietbergen H, Hermens Y, Mirakhur R. Recovery from shallow rocuronium induced neuromuscular blockade is consistently more rapid with sugammadex compared with neostigmine: results from a pooled analysis of phase 2 & 3 studies. European Journal of Anaesthesiology 2008; 25 (Suppl. 44): 9AP3-2.
23. van den Broek L, Proost JH, Wierda JM. Early and late reversibility of rocuronium bromide. European Journal of Anesthesiology 1994; 11 (Suppl. 9): 128-32.
24. Sparr HJ, Vermeyen KM, Beaufort AM, et al. Early reversal of profound rocornium-induced neuromuscular blockade by sugammadex in a randomised multi-centre study. Anesthesiology 2007; 106: 935-43.
25. Groudine SB, Soto R, Lien C, Drover D, Roberts K. Randomised, dose finding, phase 2 study of the selective relaxant binding drug, sugammadex, capable of safely reversing profound rocuronium-induced neuromuscular block. Anaesthesia and Analgesia 2007; 104: 555-62.
26. Duvaldestin P, Kuizenga K, Kjaer CC, Saldien V, Debaene B. Sugammadex achieves fast recovery from profound neuromuscular blockade induced by rocuronium or vecuronium: a dose response study. European Journal of Anesthesiology 2007; 24 (Suppl. 39): 123.
27. Jones RK, Caldwell JE, Brull SJ, Soto RG. Reversal of profound rocuronium-induced blockade with sugammadex, a randomized comparison with neostigmine. Anesthesiology 2008; 109: 816-24.
28. Benumof JL, Dagg R, Benmuof R. Critical haemoglobin desaturation will occur before return to an unparalysed state following 1 mg/kg intravenous succinylcholine. Anaesthesiology 1997; 87: 979-82.
29. Hayes AH, Breslin DS, Mirakhur R, Reid JE, O'Hare RA. Frequency of haemoglobin desaturation with the use of succtylcholine during rapid sequence induction of anaesthesia. Acta Anaesthesialogica Scandinavica 2001; 45: 746-9.
30. de Boer HD, Driessen JJ, Marcus MAE, Kerkkamp H, Heeringa M, Klimek M. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex. Anesthesiology 2007; 107: 239-44.
31. Pühringer FK, Rex C, Sielenkamber AW, et al. Reversal of profound, high dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points. An international multicenter, randomised, dose finding, safety assessor-blinded, phase 2 trial. Anaesthesiology 2008; 109: 188-97.
32. McCourt KC, Salmela L, Mirkahur RK, et al. Comparison of rocuronium and suxanethonium for use during rapid sequence induction of anaesthesia. Anaesthesia 1998; 53: 867-71.
33. Heier T, Caldwell JE. Rapid tracheal intubation with large dose rocuronium: a probability based approach. Anaesthesia and Analgesia 2000; 90: 175-9.
34. Lee C, Jahr JS, Candiotti K, Warriner V, Zornow MH. Reversal of profound rocuronium NMV with sugammadex is faster than recovery from succinylcholine. Anesthesiology 2007; 107: A988.
35. Hope FG, Bom AH. Sugammadex restores spontaneous respiration after profound blockade with rocuronium. Anesthesiology 2008; 109: a356.
36. Miller S, Bom A. Org 25969 causes selective reversal of neuromuscular blockade induced by steroidal NMB's in the mouse hemi-diaphragm preparation. European Journal of Anesthesiology 2001; 18 (Suppl. S23): 100-1.
37. Hope F, Bom A. Rapid reversal of vecuronium induced block with sugammadex in 3 species. European Journal of Anesthesiology 2006; 23 (Suppl. 37): 139.
38. Alvarez-Gomez JA, Wattwill M, Vanacker B, Lora-Damayo JI, Khunl-Brady KS. Reversal of vecuronium induced shallow neuromuscular blockade is significantly faster with sugammadex compared with neostigmine. European Journal of Anesthesiology 2007; 24 (Suppl. 39): 124-5.
39. Lemmens HJM, El-Orbany MI, Verry J, Martin G. Sugammadex reverses profound vecuronium blockade more rapidly than neostigmine. Anesthesiology 2007; 107: A1578.
40. Khunel-Brady K, Rietbergen H, Prins M, Mirakhur R. Reversal of shallow vecuronium induced neuromuscular blockade is achieved more rapidly with sugammadex than with neostigmine: a pooled analysis of phase 2 & 3 clinical trials. European Journal of Anesthesiology 2008; 25 (Suppl. 44): 9AP5-10.
41. McDonagh DL, Benedict BE, Kovac AL, Drover D, Brister NW. Efficacy and safety of sugammadex for reversal of rocuronium induced blockade in elderly patients. Anesthesiology 2007; 107: a1583.
42. McCarthy GJ, Cooper R, Stanley JC, Mirakhur RK. Dose response relationships for neostigmine antagonism of vecuronium induced neuromuscular block in adults and the elderly. British Journal of Anaesthesia 1992; 69: 281-3.
43. Lowry DW, Mirakhur RK, McCarthy GJ, Carroll MT, McCourt KC. Neuromuscular effects of rocuronium during sevoflurane, isoflurane and intravenous anaesthesia. Anaesthesia and Analgesia 1998; 87: 936-40.
44. Reid JE, Breslin DS, Mirakhur RK, Hayes AH. Neostigmine antagonism of rocuronium block during anaesthesia with sevoflurane, isoflurane or propofol. Canadian Journal of Anaesthesia 2001; 48: 351-5.
45. Vanacker BV, Vermeyen KM, Struys MRF, et al. Reversal of rocuronium induced neuromuscular block with the novel drug sugammadex is equally effective under maintenance anaesthesia with propofol or sevoflurane. Anaesthesia and Analgesia 2007; 104: 563-8.
46. Mirakhur RK, McCarthy GJ. Basic pharmacology of reversal agents, in, anaesthesiology. Clinics of North America 1993; 11: 237-50.
47. Cozanitis DA, Dundee JW, Jones CJ, Merrett JD, Mirakhur RK. An evaluation of glycopyrrolate and atropine as adjuncts to reversal of non-depolarising neuromuscular blocking agents in a true-to-life situation. British Journal of Anaesthesia 1980; 52: 85-9.
48. Mirakhur RK, Dundee JW, Jones CJ, Coppel DL, Clarke RSJ. Reversal of neuromuscular blockade: those determination studies with atropine and glycopyrrolate given before or in a mixture with neostigmine. Anaesthesia and Analgesia 1981; 60: 557-62.
49. Flockton EA, Mastronardi P, Hunter JM, et al. Reversal of rocuronium induced neuromuscular block with sugammadex is faster than reversal of cisatracurium induced block with neostigmine. British Journal of Anaesthesia 2008; 100: 622-30.
50. Dahl V, Pendeville BE, Hollman MW, Heier T, Blobner M. Reversal of rocuronium induced neuromuscular blockade by sugammadex in cardiac patients. Anesthesiology 2007; 107: A1581.
51. Cammu G, De Kam PJ, Demeyer I, et al. Safety and tolerability of single intravenous doses of sugammadex administered simultaneously with rocuronium or vecuronium in healthy volunteers. British Journal of Anaesthesia 2008; 100: 373-9.
52. Plaud B, van Heumen E, Zwiers A. Sugammadex is well tolerated for the reversal of rocuronium or vecuronium induced neuromuscular blockade in a pooled analysis of adverse events in 10 placebo controlled trials. European Journal of Anesthesiology 2008; 25 (Suppl. 44): 9AP3-3.
53. http://www.fda.gov/ohrms/dockets/ac/08/slides/2008-4346s1-01-Schering- Plough-corebackup.pdf.
54. Mirakhur RK, Lavery TD, Briggs LP, Clarke RSJ. Effects of neostigmine and pyridostigmine on serum cholinesterase activity. Canadian Anaesthetists' Society Journal 1982; 29: 55-8.
55. Bom A, Hope F. Neuromuscular block induced by rocuronium and reversed by the encapsulating agent Org 25969 can be re-established using the non-sterodial neuromuscular blockers succinylcholine and cis-atracurium. European Journal of Anaesthesiology 2005; 22 (Suppl. 34): 120.
56. de Boer HD, Driessen JJ, van Egmond J, Booij LHDJ. Nonsteroidal neuromuscular blocking agents to re-establish paralysis after reversal of rocuronium-induced neuromuscular block with sugammadex. Canadian Journal of Anaesthesia 2008; 55: 124-5.